These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2506570)

  • 21. [Phospholipid metabolism in vascular endothelial cells].
    Arita H
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):216-21. PubMed ID: 1902582
    [No Abstract]   [Full Text] [Related]  

  • 22. [Arachidonic acid metabolites and shock].
    Förster W
    Z Gesamte Inn Med; 1985 Apr; 40(8):217-21. PubMed ID: 3925652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversible inhibition of thromboxane A2 production by imidazole 2-hydroxybenzoate (ITF 182) in the arachidonic acid injected rat. A comparison with acetylsalicylic acid and indometacin.
    Pagella PG; Agozzino S; Bellavite O; Donà GC
    Arzneimittelforschung; 1984; 34(5):597-8. PubMed ID: 6432000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metabolic pathways of arachidonic acid: prostaglandins, thromboxane and leukotrienes].
    Maclouf J
    Arch Mal Coeur Vaiss; 1985 Dec; 78 Spec No():21-7. PubMed ID: 3938940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of arachidonic acid by lipoxygenase and cyclooxygenase activities: qualitative and quantitative aspects.
    Galli G; Bosisio E; Sautebin L
    Prog Food Nutr Sci; 1980; 4(5):9-11. PubMed ID: 6779349
    [No Abstract]   [Full Text] [Related]  

  • 26. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
    Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C
    J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid inflammatory mediators in glomerulonephritis.
    Lianos EA
    J Lab Clin Med; 1989 May; 113(5):535-6. PubMed ID: 2497217
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolism of arachidonic acid.
    Moncada S; Higgs EA
    Ann N Y Acad Sci; 1988; 522():454-63. PubMed ID: 3132072
    [No Abstract]   [Full Text] [Related]  

  • 29. Roles of thromboxanes in gastrointestinal physiopathology.
    Bennett TA
    Int J Tissue React; 1983; 5(3):237-9. PubMed ID: 6686219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiinflammatory drugs and the many mediators of inflammation.
    Vane JR
    Int J Tissue React; 1987; 9(1):1-14. PubMed ID: 3110088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of the effects of inhibition of pulmonary thromboxane A2 synthase activity, in vivo and in vitro.
    McNamara DB; Kerstein MD; Harrington JK; Bellan JA; Graybar GB; Hyman AL; Kadowitz PJ
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():531-4. PubMed ID: 2526532
    [No Abstract]   [Full Text] [Related]  

  • 32. Significance of lipid mediators in shock states.
    Lefer AM
    Circ Shock; 1989 Jan; 27(1):3-12. PubMed ID: 2492907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of vasoactive cyclooxygenase products on shunt flow and extravascular lung water in acute lung injuries].
    Yamaguchi K; Mori M; Takasugi T; Oyamada Y; Kawai A; Asano K; Aoki T; Fujita H; Suzuki Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Apr; 32(4):302-8. PubMed ID: 8041036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolites of arachidonic acid in the pathophysiology of the pulmonary circulation.
    Brigham KL; Newman JH; Snapper JR; Ogletree ML
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():357-66. PubMed ID: 6216788
    [No Abstract]   [Full Text] [Related]  

  • 35. Prostaglandin and thromboxane production by fibroblasts and vascular endothelial cells.
    Ali AE; Barrett JC; Eling TE
    Adv Prostaglandin Thromboxane Res; 1980; 6():533-5. PubMed ID: 6770607
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biochemical, pharmacological and therapeutic aspects of skin metabolism of arachidonic acid].
    Bouclier M; Hensby CN
    Ann Dermatol Venereol; 1986; 113(12):1289-93. PubMed ID: 3105409
    [No Abstract]   [Full Text] [Related]  

  • 37. Arachidonate metabolism in renal injury.
    Lefkowith JB; Needleman P
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():121-30. PubMed ID: 3159195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrathoracic platelet accumulation in the guinea-pig induced by intravenous administration of arachidonic acid--effect of cyclooxygenase and thromboxane synthetase inhibitors.
    Barrett PA; Butler KD; Shand RA; Wallis RB
    Thromb Haemost; 1986 Dec; 56(3):311-7. PubMed ID: 3105107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical significance of prostaglandins and other arachidonic acid metabolites. Prostacyclin (PGI2), thromboxane A2, leukotriene].
    Oelz O
    Ther Umsch; 1982 Oct; 39(10):751-8. PubMed ID: 6760444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.